Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-11-04 Quart Barry D Chief Executive Officer Gift −600 0
2016-11-04 Quart Barry D Chief Executive Officer Gift +600 92,509
2016-10-31 Drazba Brian G. VP, Finance & CFO Other acquisition +538 $12.62 $7K 3,798
2016-10-07 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2016-08-10 Rosen Robert President & CCO Exercise or conversion +100,000 $7.20 $720K 102,640
2016-08-10 Rosen Robert President & CCO Sale −87,600 $23.21 $2.0M 15,040
2016-08-10 Rosen Robert President & CCO Sale −12,400 $23.89 $296K 2,640
2016-08-10 Rosen Robert President & CCO Exercise or conversion · Employee Stock Option (Right to Buy) −100,000 825,000
2016-07-19 Quart Barry D Chief Executive Officer Exercise or conversion +4,630 $7.20 $33K 66,309
2016-07-19 Quart Barry D Chief Executive Officer Exercise or conversion · Employee Stock Option (Right to Buy) −4,630 930,277
2016-06-22 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +1,000 1,000
2016-06-22 Christian Waage Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-06-22 Christian Waage Director Grant or award · Stock Option (Right to Buy) +1,500 1,500
2016-06-16 TANG KEVIN C Director Exercise or conversion +1,250,000 $3.60 $4.5M 6,117,530
2016-06-16 TANG KEVIN C Director Shares withheld for taxes −243,639 $18.47 $4.5M 5,873,891
2016-06-16 TANG KEVIN C Director Exercise or conversion · Warrant (Right to Buy) −1,250,000 0
2016-04-29 Drazba Brian G. VP, Finance & CFO Other acquisition +577 $18.22 $11K 3,260
2016-04-29 Quart Barry D Chief Executive Officer Other acquisition +837 $18.22 $15K 61,679
2016-04-21 Rosen Robert President Exercise or conversion +19,662 $7.20 $142K 22,302
2016-04-21 Rosen Robert President Sale −19,662 $22.15 $435K 2,640

Page 35 of 38 · 746 trades